Drug intelligence / Profile preview

Jing Guan Fang

Development stage
Preclinical
Lead developer
Longhua Hospital Shanghai University of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral, Inhalation
01

Overview

Jing Guan Fang (JGF) is a Traditional Chinese Medicine (TCM) decoction primarily developed for the prevention of SARS-CoV-2 infection and the treatment of cold-like symptoms. Comprised of five medicinal herbs, including *Forsythia suspensa* and components like baicalin (from *Scutellaria baicalensis*), JGF acts through multiple pathways to inhibit viral entry and modulate the host immune response. Mechanistically, it induces the lysosomal-dependent degradation of the Angiotensin-Converting Enzyme 2 (ACE2) receptor and suppresses the expression of Transmembrane Protease Serine 2 (TMPRSS2), effectively blocking the fusion and entry of coronaviruses into host lung cells. Furthermore, JGF serves as an immunomodulator by regulating the JAK/STAT3 and MAPK/JNK signaling pathways; it exhibits a dual effect, promoting basal macrophage activity while suppressing lipopolysaccharide-induced inflammatory cytokine production, such as IL-6 and TNF-α. The formula also possesses antioxidant properties, leveraging flavonoids like baicalein to scavenge reactive oxygen species and mitigate inflammation.

Other names
JGF
02

Targets

JAK2 (Janus kinase 2)ACE2 (Angiotensin-converting enzyme 2)STAT3 (Signal Transducer and Activator of Transcription 3)IL-6 (Interleukin 6)NOS2 (Nitric Oxide Synthase 2)TNFA (Tumor necrosis factor alpha (soluble))TMPRSS2 (Transmembrane protease serine 2)JNK (Mitogen-activated protein kinase kinase kinase family)MAPK3 (Mitogen-activated protein kinase 1)

Beyond the preview

Go deeper on Jing Guan Fang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jing Guan Fang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call